Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Functional neuroimaging in depression with escitalopram
2005-005739-91Phase 2Completed
- Sponsor
- Ghent University Hospital
- Start
- May 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of escitalopram in major depressive disorder (MDD), sponsored by Ghent University Hospital. Primary endpoint: Change in cognitive functions and brain metabolism with escitalopram. Started May 2006; status: completed.
02
Drugs
escitalopram
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on 2005-005739-91.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-005739-91.